在使用患者级数据进行历史借款之前,共变量调整的元分析预测 (CA-MAP) 使用患者级数据.
Bradley Hupf1, Yunlong Yang2, Ryan Gryder1
1Takeda Pharmaceuticals, Cambridge, MA, United States.
Journal of biopharmaceutical statistics
|April 2, 2024
概括
这项研究引入了一种新的共变量调整的元分析预测 (CA-MAP) 方法,用于药物开发中的历史控制借款. 该方法通过关注共同变量效应相似性,而不仅仅是结果相似性,以克服试验异质性,从而增强借用.
科学领域:
- 生物统计学 生物统计学
- 药学指标 (Pharmacometrics) 是一个指标.
- 临床试验设计 临床试验设计
背景情况:
- 在药物开发中使用历史数据的效率越来越高.
- 试验间的异质性对标准化历史数据借用方法构成重大挑战.
- 现有的方法往往会根据结果相似性扣除历史数据,这可能是误导性的,因为实验的内在变化.
研究的目的:
- 在历史控制借款之前提出一种新的共同变量调整后元分析预测 (CA-MAP).
- 解决当前方法在处理试验间异质性和共变量分布差异方面的局限性.
- 通过专注于共同变量效应的一致性,使历史数据的借用更有效.
主要方法:
- 开发一个CA-MAP,在每个共变量效应之前分配一个MAP.
- 直接对共变量效应进行建模,以确定借来的信息量.
- 整合试验间异质性与共变量级异质性,以微调历史数据借用.
主要成果:
- 在CA-MAP之前,借款可以通过跨历史和当前数据的共同变量效应的一致性来确定.
- 该方法有效地处理了人口水平结果总结不同但共同变量效应保持一致的场景.
- 这种方法提供了一种独特的方式,可以通过直接建模共变量效应来利用历史数据.
结论:
- 拟议的MAP前期患者级扩展为历史对照借款提供了一个强大的方法.
- 借贷的有效性通过基于共变效应的相似性而不是临床结果来提高.
- 这有助于在药物开发决策中更可靠,更有效地利用历史数据.
相关概念视频
Bias in Epidemiological Studies
256
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
256
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Statistical Methods for Analyzing Epidemiological Data
364
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
364
Mechanistic Models: Compartment Models in Individual and Population Analysis
39
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
39
Confounding in Epidemiological Studies
169
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
169
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K


